+ A
A -
Tribune News Network
Doha
Hamad Medical Corporation (HMC) and Qatar Pharma for Pharmaceutical Industries have signed a three-year framework contract agreement for the supply of medicines and medical supplies.
This agreement comes within the framework of the joint efforts of the Ministry of Commerce and Industry and Hamad Medical Corporation to support national industries and to underscore the ability of local products to ensure Qatar’s self-sufficiency.
Mohamed Hassan Al Malki, Assistant Undersecretary for Industry Affairs, stressed that this cooperation is part of mninistry’s efforts at supporting the role of national companies in achieving the state’s self-sufficiency in various sectors, especially in pharmaceutical industries, which is one of the vital sectors.
The initiative instills a true partnership with the private sector, and supports the economic growth of non-oil sectors, in line with the economic diversification plans pursued by Qatar to achieve the objectives of its National Vision 2030 and Qatar National Manufacturing Strategy 2018-2022, Al Malki added.
The agreement was signed by Mahmoud Saleh Al Raisi, Chief of Continuing Care Group and Chairman of the Tender Committee at Hamad Medical Corporation, and Dr Ahmed Mohamed Al Sulaiti, Chairman of Qatar Pharma for Pharmaceutical Industries.
Abdulbasit Talib Al Ajji, Director of the National Product Competitiveness Support Department at the Ministry, expressed his happiness at signing the agreement.
The agreement is a continuation of the ministry’s efforts to support national industries through coordination and linking manufacturers and suppliers with government agencies in Qatar to ease the process of purchasing local products and enhances their competitiveness against imported products, thus protecting national products, and increasing consumer access to them, Al Ajji said.
Al Ajji added that the works would be completed by signing agreements and contracts with other manufacturers within the medical and other sectors during the coming period.
Al Raisi welcomed the signing of this agreement, which will contribute to providing medicines and medical supplies to HMC during the next three years.
He stressed that the corporation had been seeking, since its establishment, to support initiatives, programmes, and projects that contribute to promoting national products used in the medical field, in addition to its keenness to build effective partnerships with various governmental and private bodies and institutions in various fields in Qatar.
Dr Al Sulaiti assured that signing the agreement with HMC reflected the state’s efforts to support the industrial sectors, especially the pharmaceutical industry, comprising a significant revenue source in the national economy. This agreement will open up broader horizons and fields for the development of the pharmaceutical industry and will expand the establishment of more factories to meet the state’s increasing needs, Dr Al Sulaiti said.
This step contributes to achieving self-sufficiency in this vital sector in line with the state’s strategy and vision in this regard, he added.
Furthermore, this endeavor will support the competitive position of national products against global products of the like, in addition to enhancing the company’s competitive capabilities, increasing its export capabilities, and opening new markets for it, Dr Al Sulaiti explained.
Doha
Hamad Medical Corporation (HMC) and Qatar Pharma for Pharmaceutical Industries have signed a three-year framework contract agreement for the supply of medicines and medical supplies.
This agreement comes within the framework of the joint efforts of the Ministry of Commerce and Industry and Hamad Medical Corporation to support national industries and to underscore the ability of local products to ensure Qatar’s self-sufficiency.
Mohamed Hassan Al Malki, Assistant Undersecretary for Industry Affairs, stressed that this cooperation is part of mninistry’s efforts at supporting the role of national companies in achieving the state’s self-sufficiency in various sectors, especially in pharmaceutical industries, which is one of the vital sectors.
The initiative instills a true partnership with the private sector, and supports the economic growth of non-oil sectors, in line with the economic diversification plans pursued by Qatar to achieve the objectives of its National Vision 2030 and Qatar National Manufacturing Strategy 2018-2022, Al Malki added.
The agreement was signed by Mahmoud Saleh Al Raisi, Chief of Continuing Care Group and Chairman of the Tender Committee at Hamad Medical Corporation, and Dr Ahmed Mohamed Al Sulaiti, Chairman of Qatar Pharma for Pharmaceutical Industries.
Abdulbasit Talib Al Ajji, Director of the National Product Competitiveness Support Department at the Ministry, expressed his happiness at signing the agreement.
The agreement is a continuation of the ministry’s efforts to support national industries through coordination and linking manufacturers and suppliers with government agencies in Qatar to ease the process of purchasing local products and enhances their competitiveness against imported products, thus protecting national products, and increasing consumer access to them, Al Ajji said.
Al Ajji added that the works would be completed by signing agreements and contracts with other manufacturers within the medical and other sectors during the coming period.
Al Raisi welcomed the signing of this agreement, which will contribute to providing medicines and medical supplies to HMC during the next three years.
He stressed that the corporation had been seeking, since its establishment, to support initiatives, programmes, and projects that contribute to promoting national products used in the medical field, in addition to its keenness to build effective partnerships with various governmental and private bodies and institutions in various fields in Qatar.
Dr Al Sulaiti assured that signing the agreement with HMC reflected the state’s efforts to support the industrial sectors, especially the pharmaceutical industry, comprising a significant revenue source in the national economy. This agreement will open up broader horizons and fields for the development of the pharmaceutical industry and will expand the establishment of more factories to meet the state’s increasing needs, Dr Al Sulaiti said.
This step contributes to achieving self-sufficiency in this vital sector in line with the state’s strategy and vision in this regard, he added.
Furthermore, this endeavor will support the competitive position of national products against global products of the like, in addition to enhancing the company’s competitive capabilities, increasing its export capabilities, and opening new markets for it, Dr Al Sulaiti explained.
